Plain-English translation of NCT07474220 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying a protein called SLC25A48 that helps cells process an important nutrient called choline. They want to understand how this protein works differently in people with COPD compared to people without lung disease, and whether it plays a role in how the disease gets worse over time.
COPD causes serious damage to the lungs and affects how the body handles inflammation and nutrition. This study exists because scientists think a protein involved in how cells process nutrients may be linked to COPD progression, but no one has fully studied this connection yet.
You likely qualify if…
You likely don't qualify if…
You will visit the hospital for testing and blood draws. The researchers will check your lung function, measure your nutrition and quality of life, and take a small blood sample to study the SLC25A48 protein and related inflammatory markers. The study takes place at multiple hospitals and will follow you over time to see how your condition changes.
AI-generated summary from trial data · Jul 20, 2026 · Not medical advice
Taiwan
Enrollment target
~180 participants
Started
June 2026
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ke-Yun Chao, PhD
Fu Jen Catholic University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.